Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5279
OCS
Oculis Holding AG - Ordinary shares
13.12 USD+1.47%-4.09%+15.29%-27.79%0 USD
5292
ANL
Adlai Nortye Ltd - American Depositary Shares
10.63 USD+15.54%+5.04%+5.77%+594.77%0 USD
5579
CELG-RT
Bristol-Myers Squibb Company Celegne Contingent Value Rights
0.1100 USD+5.77%+19.05%+0.92%+333.07%0 USD
6416
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-83.33%0 USD

Frequently asked questions about Novo Nordisk A/S

What is the Novo Nordisk A/S stock price today?

The current price of Novo Nordisk A/S (NVO) is 50.54. Over the past 24 hours, the stock has changed by +2.97%. Follow the NVO chart for real-time price dynamics.

What is the stock ticker of Novo Nordisk A/S?

Novo Nordisk A/S trades under the ticker NVO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Novo Nordisk A/S stock going up?

NVO has changed by +3.76% over the last week, +12.46% over the last month, and -23.60% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Novo Nordisk A/S release financial reports?

Yes. You can track Novo Nordisk A/S financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Novo Nordisk A/S have?

As of the latest available data, Novo Nordisk A/S has 69.5 K employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Novo Nordisk A/S stock?

You can buy Novo Nordisk A/S (NVO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Novo Nordisk A/S stock?

Investing in Novo Nordisk A/S requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVO chart and related analysis on metatrader.com as part of your research.

Novo Nordisk A/S

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices. Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations. The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark.

News